Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery

Comparison of Efficacy, Safety and Costs of Recombinant FVIII Products Between On-demand and Secondary Prophylaxis Groups in Haemophilia A Patients

NCT01817868 ·Status: COMPLETED

Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment

NCT02396862 ·Status: COMPLETED

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)

NCT00586521 ·Status: COMPLETED ·Phase: PHASE4

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

NCT00932555 ·Status: COMPLETED

Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis

NCT02263066 ·Status: COMPLETED

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A

NCT00782470 ·Status: COMPLETED

Kogenate FS Regulatory Post-Marketing Surveillance

NCT01386268 ·Status: COMPLETED

International PMS Study - KOGENATE Bayer

NCT00864552 ·Status: COMPLETED

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

NCT00623480 ·Status: COMPLETED ·Phase: PHASE3

Prophylaxis Versus On-demand Therapy Through Economic Report

NCT01159587 ·Status: COMPLETED

Comparative Pharmacokinetic Study of Two Different Strengths of BAY14-2222

NCT01653639 ·Status: COMPLETED ·Phase: PHASE1

Prophylaxis Versus on Demand Treatment for Children With Hemophilia A

NCT01810666 ·Status: COMPLETED ·Phase: PHASE4

A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

NCT02250560 ·Status: COMPLETED ·Phase: PHASE3

Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration

NCT01184820 ·Status: COMPLETED ·Phase: PHASE1

Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A

NCT02971930 ·Status: COMPLETED

Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980

NCT00629837 ·Status: COMPLETED ·Phase: PHASE1

A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A

NCT01580293 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes.

NCT00245297 ·Status: COMPLETED ·Phase: PHASE2

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

NCT00092976 ·Status: COMPLETED ·Phase: PHASE4

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

NCT01913405 ·Status: COMPLETED ·Phase: PHASE3

Drug Use Investigation of Kovaltry in Hemophilia A Patients

NCT02941783 ·Status: COMPLETED

A Trial to Compare Prophylaxis Therapy to On-demand Therapy With a New Full Length Recombinant FVIII in Patients With Severe Hemophilia A

NCT01233258 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659 ·Status: COMPLETED ·Phase: PHASE3

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

NCT05568719 ·Status: RECRUITING ·Phase: PHASE3

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A

NCT00621673 ·Status: TERMINATED ·Phase: PHASE4